BREAST IMAGING MARKET ANALYSIS

Key Developments

• In November 2023, GE Healthcare, a healthcare company, announced the launch of MyBreastAI Suit, an all-in-one platform of artificial intelligence (AI) app to support clinicians with breast cancer detection and improved workflow productivity. MyBreastAI Suite integrates three artificial intelligence (AI) applications from iCAD including ProFound AI for DBT, SecondLook for 2D Mammography and PowerLook Density Assessment to help support early detection and improve patient outcomes, as well as help radiology departments improve operational productivity.
• In January 2023, Seno Medical, a medical imaging company, announced an agreement Genetik, Inc., a biotechnology company, to market, sell, and service the company’s groundbreaking Imagio Opto-Acoustic/Ultrasound (OA/US) Breast Imaging System
• In December 2020, Hologic Inc., a medical technology company primarily focused on improving women’s health, announced the U.S. Food and Drug Administration (FDA) clearance and commercial availability of Genius AI Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images